Prostatic Neoplasms Clinical Trials
0 recruiting
Showing 1–20 of 32 trials
Recruiting
Phase 1
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Prostatic Neoplasms
Janssen Research & Development, LLC140 enrolled6 locationsNCT07082920
Recruiting
Phase 2
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Prostate CancerProstate AdenocarcinomaProstatic Neoplasms
National Cancer Institute (NCI)42 enrolled1 locationNCT05616650
Recruiting
Phase 1
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Prostatic Neoplasms
Janssen Research & Development, LLC40 enrolled3 locationsNCT07319871
Recruiting
Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prostate CancerProstatic Neoplasms
Clarity Pharmaceuticals Ltd383 enrolled27 locationsNCT06056830
Recruiting
Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled274 locationsNCT06925737
Recruiting
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Prostate CancerProstatic Neoplasms
National Cancer Institute (NCI)300 enrolled1 locationNCT01834001
Recruiting
Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC1,314 enrolled320 locationsNCT06136650
Recruiting
A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
Prostatic Neoplasms
Janssen Cilag S.A.S.270 enrolled1 locationNCT07451002
Recruiting
Phase 1Phase 2
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Prostate CancerMetastatic Castration-resistant Prostate CancerUrogenital Neoplasms+3 more
Blue Earth Therapeutics Ltd82 enrolled19 locationsNCT05413850
Recruiting
Phase 2
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Prostate CancerProstate AdenocarcinomaProstatic Neoplasms
Icahn School of Medicine at Mount Sinai120 enrolled1 locationNCT07285057
Recruiting
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
Prostatic Neoplasms
Bayer1,400 enrolled1 locationNCT07406282
Recruiting
Not Applicable
Prostate Adaptive Radiation Therapy
Prostatic Neoplasms
Royal North Shore Hospital130 enrolled1 locationNCT06547398
Recruiting
Not Applicable
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
Hot FlashesVasomotor SymptomsAndrogen Deprivation Therapy+2 more
Inova Health Care Services24 enrolled1 locationNCT07335224
Recruiting
Lymphedema After Urologic Surgery
Urinary Bladder NeoplasmsPenile CancerProstatic Neoplasms+1 more
Vastra Gotaland Region400 enrolled2 locationsNCT05264337
Recruiting
Prostate Active Surveillance Study
Prostatic Neoplasms
University of Washington3,000 enrolled11 locationsNCT00756665
Recruiting
Phase 1
A Study of DM002 in Patients With Advanced Solid Tumors
Ovarian NeoplasmsColorectal NeoplasmsEndometrial Neoplasms+2 more
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.160 enrolled5 locationsNCT06751329
Recruiting
Men at High Genetic Risk for Prostate Cancer
Prostatic Neoplasms
National Cancer Institute (NCI)500 enrolled1 locationNCT03805919
Recruiting
Phase 1Phase 2
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
Prostate CancerNeoplasmsNeoplasms by Site+7 more
Pathos AI, Inc.252 enrolled10 locationsNCT06785636
Recruiting
Phase 2
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Prostate CancerProstatic Neoplasms
Dana-Farber Cancer Institute110 enrolled3 locationsNCT05765500
Recruiting
Not Applicable
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer
Prostate CancerNeoplasmsAdenocarcinoma+2 more
Imperial College London3,600 enrolled15 locationsNCT05574647